Observing Atrial Fibrillation Before and After Cardioversion
Atrial Fibrillation Prior and Post Elective Cardioversion
This study looks at how often people with atrial fibrillation return to a normal heart rhythm on their own before a scheduled cardioversion and how often they go back to atrial fibrillation afterward.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sorlandet Hospital HF Government |
| Locations | 1 site (Arendal) |
| Trial ID | NCT05926401 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the rate at which patients with atrial fibrillation (AF) spontaneously convert to sinus rhythm (SR) prior to their scheduled elective cardioversion. Additionally, it will assess the early recurrence rate of AF following the cardioversion procedure. Patients will undergo ECG monitoring both before and after the cardioversion to gather data on these rates. The study seeks to provide insights into the natural history of AF in the context of elective cardioversion.
Who should consider this trial
Good fit: Ideal candidates for this study are patients scheduled for elective cardioversion of atrial fibrillation who can provide informed consent.
Not a fit: Patients who are unable to cooperate, have a pacemaker or CRT device, or do not possess a smartphone may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of AF dynamics, potentially leading to improved management strategies for patients undergoing cardioversion.
How similar studies have performed: While the specific approach of this study may be novel, similar observational studies have provided valuable insights into atrial fibrillation management.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Planned elective cardioversion of AF * Informed written consent for participation Exclusion Criteria: * Lack of ability to cooperate * Pacemaker/CRT device * No smart phone
Where this trial is running
Arendal
- Sorlandet Hospital — Arendal, Norway (Recruiting)
Study contacts
- Study coordinator: Jarle Jortveit, PhD
- Email: jarle.jortveit@sshf.no
- Phone: +4799450714
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.